[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Regenerative MedicineMarket

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          Product Overview

4.1       Introduction

4.1.1    Market Size & Forecast

4.2       Cell-Based Products

4.2.1    Market Size & Forecast

4.2.2     Allogeneic Products

4.2.3     Autologous Products

4.3       Acellular Products

4.3.1    Market Size & Forecast

5          Therapy Overview

5.1       Introduction

5.1.1    Market Size & Forecast

5.2       Cell Therapy

5.2.1    Market Size & Forecast

5.3       Tissue Engineering

5.3.1    Market Size & Forecast

5.4       Immunotherapy

5.3.1    Market Size & Forecast

5.5       Gene Therapy

5.3.1    Market Size & Forecast

6          Application Overview

6.1       Introduction

6.1.1    Market Size & Forecast

6.2       Orthopedic & Musculoskeletal Disorders

6.2.1    Market Size & Forecast

6.3       Dermatology

6.3.1    Market Size & Forecast

            6.4       Cardiology

6.4.1    Market Size & Forecast

6.5       Central Nervous System Diseases

6.5.1    Market Size & Forecast

6.6       Oncology

6.6.1    Market Size & Forecast

6.7       Diabetes

6.7.1    Market Size & Forecast

6.8       Other Applications

6.8.1    Market Size & Forecast

7          Regional Overview

7.1       Introduction

7.1.1    Market Size & Forecast

7.2       America

7.2.1    North America

7.2.1.1 U.S.

7.2.1.1.1          By Product

7.2.1.1.2          By Therapy

7.2.1.1.3          By Application

7.2.1.2 Canada

7.2.1.2.1          By Product

7.2.1.2.2          By Therapy

7.2.1.2.3          By Application

7.2.1.3 Mexico

7.2.1.3.1          By Product

7.2.1.3.2          By Therapy

7.2.1.3.3          By Application

7.2.2    Latin America

7.2.2.1             By Product

7.2.4.2             By Therapy

7.2.4.3             By Application

7.3       Europe

7.3.1    Market Size & Forecast

7.3.2    Germany

7.3.2.1 By Product

7.3.2.2 By Therapy

7.3.2.3 By Application

7.3.3    France

7.3.3.1 By Product

7.3.3.2 By Therapy

7.3.3.3 By Application

7.3.4    U.K

7.3.4.1 By Product

7.3.4.2 By Therapy

7.3.4.3 By Application

7.3.5    Italy

7.3.5.1 By Product

7.3.5.2 By Therapy

7.3.5.3 By Application

7.3.6    Spain

7.3.6.1 By Product

7.3.6.2 By Therapy

7.3.6.3 By Application

7.3.7    Rest of Europe

7.3.7.1 By Product

7.3.7.2 By Therapy

7.3.7.3 By Application

7.4       AsiaPacific

7.4.1    Market Size & Forecast

7.4.2    Japan

7.4.2.1 By Product

7.4.2.2 By Therapy

7.4.2.3 By Application

7.4.3    China

7.4.3.1 By Product

7.4.3.2 By Therapy

7.4.3.3 By Application

7.4.4    Australia

7.4.4.1 By Product

7.4.4.2 By Therapy

7.4.4.3 By Application

7.4.5    India

7.4.5.1 By Product

7.4.5.2 By Therapy

7.4.5.3 By Application

7.4.6    South Korea

7.4.6.1 By Product

7.4.6.2 By Therapy

7.4.6.3 By Application

7.4.7    Rest of Asia-Pacific

7.4.7.1 By Product

7.4.7.2 By Therapy

7.4.7.3 By Application

7.5       Middle East & Africa

7.5.1    Market Size & Forecast

7.5.2    Saudi Arabia

7.5.2.1 By Product

7.5.2.2 By Therapy

7.5.2.3 By Application

7.5.3    South Africa

7.5.3.1 By Product

7.5.3.2 By Therapy

7.5.3.3 By Application

7.5.4    Brazil

7.5.4.1 By Product

7.5.4.2 By Therapy

7.5.4.3 By Application

7.5.5    Rest of Middle East & Africa

7.5.5.1 By Product

7.5.5.2 By Therapy

7.5.5.3 By Application

8          Company Profile

8.1       Nuvasive, Inc.

8.1.1    Company Overview

8.1.2    Financial Performance

8.1.3    Recent Developments

8.1.4    Product Portfolio

8.2       Acelity L.P. Inc.

8.2.1    Company Overview

8.2.2    Financial Performance

8.2.3    Recent Developments

8.2.4    Product Portfolio

8.3       Osiris Therapeutics, Inc.

8.3.1    Company Overview

8.3.2    Financial Performance

8.3.3    Recent Developments

8.3.4    Product Portfolio

8.4       Organogenesis Inc.

8.4.1    Company Overview

8.4.2    Financial Performance

8.4.3    Recent Developments

8.4.4    Product Portfolio

8.5       Medtronic PLC

8.5.1    Company Overview

8.5.2    Financial Performance

8.5.3    Recent Developments

8.5.4    Product Portfolio

8.6       Vericel Corporation

8.6.1    Company Overview

8.6.2    Financial Performance

8.6.3    Recent Developments

8.6.4    Product Portfolio

8.7       Cook Biotech Incorporated

8.7.1    Company Overview

8.7.2    Financial Performance

8.7.3    Recent Developments

8.7.4    Product Portfolio

8.8       Stryker Corporation

8.8.1    Company Overview

8.8.2    Financial Performance

8.8.3    Recent Developments

8.8.4    Product Portfolio

8.9       Japan Tissue Engineering Co., Ltd.

8.9.1    Company Overview

8.9.2    Financial Performance

8.9.3    Recent Developments

8.9.4    Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports